ISONOVA

Live / Registered — Registered (as of 25 Feb 2025)

What this means for you

Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number: 98510322
Registration number: 7702936
Mark type: Stylized text
Filed: 19 Apr 2024
Published for opposition: 07 Jan 2025
Registered: 25 Feb 2025
Attorney of record: Lindsay B. Allen

Goods and services

Class 009 — Scientific and electric apparatus: Downloadable software for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering drugs, designing drug candidates, biologic product development, and pharmaceutical product development; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, machine learning methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies, for protein structure prediction, l drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; downloadable computer software for conducting therapeutic product research and development; downloadable computer software for discovering, optimizing and developing drugs; downloadable computer software for designing and developing drug candidates
Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for protein structure prediction, drug discovery, drug candidate design, biological product development, and pharmaceutical product development; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, or reinforcement learning for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; platform as a service (PaaS) services featuring software for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; platform as a service (PaaS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, drug discovery, development of biologic materials, development of biologic products, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; providing online, non-downloadable computer software platforms for protein structure prediction, drug discovery, drug candidate design, biologic material development, , and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, or reinforcement learning for protein structure prediction, drug discovery, drug candidate design, biological produce development, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; scientific, pharmaceutical, biotech, medical, and artificial intelligence research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, biotech research, protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; product research and development; medical, pharmaceutical, biotech, and scientific research in the field of protein structure prediction, drug discovery, drug candidate design, biologic product development, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning, virtual reality, science, chemistry, medicinal chemistry, physics, biology, and digital biology, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, medicinal chemistry, physics, biology, and digital biology, all for protein structure prediction, drug discovery, drug candidate design, biologic product development, and pharmaceutical product development; computer modelling services; technical or scientific services for the analysis of compositions of matter; technical consulting in the field of pharmaceutical studies; drug discovery, drug design, optimization and development services; research and development of therapeutic products; drug discovery, optimization and development services; medical and scientific services in the field of pharmaceuticals, namely, therapeutic and diagnostic candidate design services

Owner

Prosecution history

25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07 Jan 2025 — PUBLISHED FOR OPPOSITION
01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
14 Dec 2024 — EXAMINER'S AMENDMENT ENTERED
14 Dec 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14 Dec 2024 — EXAMINERS AMENDMENT E-MAILED
14 Dec 2024 — EXAMINERS AMENDMENT -WRITTEN
12 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
12 Nov 2024 — NON-FINAL ACTION E-MAILED
12 Nov 2024 — NON-FINAL ACTION WRITTEN
04 Nov 2024 — ASSIGNED TO EXAMINER
07 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Marksy